InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,691.76
(
-0.31%
)
US TECH 100
19,231.60
(
-0.24%
)
Dow Jones
41,972.68
(
-0.53%
)
Brent Oil
77.67
(
4.09%
)
Bitcoin
60,761.65
(
0.23%
)
Post# of 346422
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

aikifredicist

Send PM Follow Ignore
Followers 16
Posts 395
Boards Moderated 0
Alias Born 06/07/2009

aikifredicist

Re: dia76ca post# 103928

Friday, 12/07/2012 6:39:45 PM

Friday, December 07, 2012 6:39:45 PM

Post# of 346422
From recent postings:

You may get your wish , i.e. much faster approvals.

From NYTimes:
"Ruling Is Victory for Drug Companies in Promoting Medicine for Other Uses"
http://www.nytimes.com/2012/12/04/business/ruling-backs-drug-industry-on-off-label-marketing.html?nl=todaysheadlines&emc=edit_th_20121204&_r=0


Is the conventional Phase III pathway appropriate for a potentially revolutionary drug like Bavi?
Once again I recommend viewing this week's BioCentury webcast:
http://www.biocenturytv.com/player/2000894425001/2003420183001
. The new FDA Breakthrough Pathway seems taylor made for a drug like Bavi.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Start posting your company's news
Only $200 per official company press release!